Evidence map›Paper›PMID 26603129›Full record

ArticleBioconjugate chemistry2016

Synthesis and Testing of Modular Dual-Modality Nanoparticles for Magnetic Resonance and Multispectral Photoacoustic Imaging.

Alexei A Bogdanov, Adam J Dixon, Suresh Gupta, Lejie Zhang, Shaokuan Zheng, Mohammed S Shazeeb, Surong Zhang, Alexander L Klibanov

Abstract read
In one paragraph

Article in Bioconjugate chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Molecular Imaging in Nanotechnology and Theranostics.Molecular imaging and biology · 2017
    Review
  6. Oxidation-Responsive, EuACS omega · 2017
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Alexei A Bogdanov
Adam J DixonDepartment of Biomedical Engineering, University of Virginia , Charlottesville, Virginia 22904, United States.
Suresh Gupta
Lejie Zhang
Shaokuan Zheng
Mohammed S Shazeeb
Surong Zhang
Alexander L KlibanovDepartment of Biomedical Engineering, University of Virginia , Charlottesville, Virginia 22904, United States.
University of Virginia · US

Funding

MR SIGNAL AMPLIFICATION FOR RECEPTOR IMAGINGR01EB000858 · NIBIB · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI BOGDANOV, ALEXEI A. · 2003 to 2022
$6.0M
Molecular fluorescence lifetime sensor of pro-inflammatory signaling in diabetesR01DK095728 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI BOGDANOV, ALEXEI A. · 2014 to 2017
$1.5M
Molecular Imaging Probes for Reporting on Vascular Oxidative ResponseR01AG034901 · NIA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI BOGDANOV, ALEXEI A. · 2010 to 2013
$1.3M
Transmission Electron Microscope for Core EM FacilityS10RR027897 · NCRR · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CRAIG, ROGER W · 2009 to 2009
$500k
Scanning Electron Microscope for Core EM FacilityS10RR021043 · NCRR · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CRAIG, ROGER W · 2007 to 2007
$498k
Optimization and In vivo Testing of a Novel Combination HIV MicrobicideR21AI108529 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI BOGDANOV, ALEXEI A. · 2014 to 2015
$459k
Engineering of multi-functional nucleolin-targeted nucleic acid delivery system.R21EB017980 · NIBIB · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI ZHANG, SURONG · 2014 to 2015
$418k
NCRR NIH HHS S10 RR021043NCRR NIH HHS S10RR021043NCRR NIH HHS S10 RR027897NCRR NIH HHS S10RR027897NIAID NIH HHS R21 AI108529NIA NIH HHS 5R01AG034901-04NIA NIH HHS R01 AG034901NIBIB NIH HHS 2R01EB000858-10NIBIB NIH HHS R01 EB000858NIBIB NIH HHS R21 EB017980NIBIB NIH HHS R21EB017980-01NIDDK NIH HHS R01 DK095728
6 · The paper itself

Abstract

Magnetic resonance (MR) and photoacoustic (PA) imaging are currently being investigated as complementing strategies for applications requiring sensitive detection of cells in vivo. While combined MR/PAI detection of cells requires biocompatible cell labeling probes, water-based synthesis of dual-modality MR/PAI probes presents significant technical challenges. Here we describe facile synthesis and characterization of hybrid modular dextran-stabilized gold/iron oxide (Au-IO) multimetallic nanoparticles (NP) enabling multimodal imaging of cells. The stable association between the IO and gold NP was achieved by priming the surface of dextran-coated IO with silver NP resulting from silver(I) reduction by aldehyde groups, which are naturally present within the dextran coating of IO at the level of 19-23 groups/particle. The Au-IO NP formed in the presence of silver-primed Au-IO were stabilized by using partially thiolated MPEG5-gPLL graft copolymer carrying residual amino groups. This stabilizer served as a carrier of near-infrared fluorophores (e.g., IRDye 800RS) for multispectral PA imaging. Dual modality imaging experiments performed in capillary phantoms of purified Au-IO-800RS NPs showed that these NPs were detectible using 3T MRI at a concentration of 25 μM iron. PA imaging achieved approximately 2.5-times higher detection sensitivity due to strong PA signal emissions at 530 and 770 nm, corresponding to gold plasmons and IRDye integrated into the coating of the hybrid NPs, respectively, with no "bleaching" of PA signal. MDA-MB-231 cells prelabeled with Au-IO-800RS retained plasma membrane integrity and were detectable by using both MR and dual-wavelength PA at 49 ± 3 cells/imaging voxel. We believe that modular assembly of multimetallic NPs shows promise for imaging analysis of engineered cells and tissues with high resolution and sensitivity.

Indexed as

Cell Line, TumorContrast MediaDextransFerric CompoundsGoldHumansMagnetic Resonance ImagingMetal NanoparticlesMultimodal ImagingNanoparticlesPhotoacoustic TechniquesContrast MediaDextransFerric Compoundsferric oxideGold

Identifiers

PMID26603129
PMCPMC4913279
OpenAlexW2275684032

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.